Physician profile
Jorge Chahla
NPI 1750891636
$916,883.99
in general payments reported to CMS, 2019-2025
19 companies · $272K in 2025
The $272K reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89K · 2020: $87K · 2021: $96K · 2022: $84K · 2023: $178K · 2024: $111K · 2025: $272K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $265K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $211K · Travel and Lodging: $67K · Food and Beverage: $10K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,500 · Honoraria: $1,000 · Education: $157 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $264,707.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $211,478.00 |
| Travel and Lodging | $67,253.67 |
| Food and Beverage | $10,238.35 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,500.00 |
| Honoraria | $1,000.00 |
| Education | $157.22 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $844,174.27 | 2019-2025 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Arthrex, INC. | $24,627.51 | 2019-2021 | |
| Linvatec Corporation | $20,975.78 | 2019-2024 | Biobrace 23mm |
| Depuy Synthes Products, INC. | $7,438.47 | 2019-2020 | |
| Synthes Gmbh | $7,309.50 | 2023-2025 | |
| Medwest Associates | $4,333.82 | 2019-2023 | |
| Stryker Corporation | $2,075.89 | 2019-2025 | Nanotack Flex, Formula, Injector |
| Medical Device Business Services, INC. | $1,671.98 | 2019 | |
| Ossur Americas, INC. | $1,590.37 | 2024-2025 | Unloader One X, Miami J |
| Vericel Corporation | $919.34 | 2021-2024 | Maci |
| Joint Restoration Foundation, INC. | $693.43 | 2019-2025 | |
| Rti Surgical, INC | $544.81 | 2021-2022 | |
| Depuy Synthes Sales INC. | $243.46 | 2019-2024 | Tfn-Advance, Na |
| Breg, INC | $124.70 | 2020 | |
| Orthofix Medical, INC. | $59.50 | 2025 | Cervical-Stim, Physio-Stim |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $40.34 | 2023 | Omnibotics 3.0 |
| Pacira Pharmaceuticals Incorporated | $31.43 | 2020 | |
| Overture Orthopaedics | $18.53 | 2025 | Overtureti |
| Si-Bone, INC. | $10.86 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,740.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Chahla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.